Condition: Generalized Myasthenia Gravis · Sponsor: argenx
The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: * The maximum trial duration for each individual participant will be approximately 28 weeks * The treatment duration will be 8 weeks for the dose-confirmatory part (Part A) and 18 weeks for the treatment response-confirmatory part (Part B)
This description comes directly from the study's public registry record.
Sabine Coppieters, MD · 857-350-4834 · ClinicalTrials@argenx.com
Always discuss trial participation with your own doctor first.
| Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital | Chicago, Illinois, United States | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| University of Virginia (UVA) Health - Developmental Pediatrics Clinic | Charlottesville, Virginia, United States | Recruiting |
| Medizinische Universitat Wien | Vienna, Austria | Completed |
| Universitair Ziekenhuis Antwerpen | Antwerp, Belgium | Recruiting |
| Alberta Childrens Hospital | Calgary, Canada | Recruiting |
| British Columbia Children's Hospital | Vancouver, Canada | Recruiting |
| AP-HM - Hopital de la Timone | Marseille, France | Recruiting |
| Assistance Publique Hopitaux de Paris (AP-HP) - Hopital Necker-Enfants Malades | Paris, France | Recruiting |
| Vian - M. Iashvili Children's Central Hospital | Tbilisi, Georgia | Completed |
| Tbilisi State Medical University - Givi Zhvania Pediatric Academic Clinic | Tbilisi, Georgia | Completed |
| Charite Universitaetsmedizin Berlin - Campus Virchow-Klinikum - Sozialpadiatrisches Zentrum | Berlin, Germany | Completed |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04833894